Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,364.00
(
0.24%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
113.04
(
8.27%
)
Bitcoin
75,943.22
(
-0.53%
)
News Focus
News Focus
Post# of 257468
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

WorstLuck

Send PM Follow Ignore
Followers 15
Posts 1659
Boards Moderated 0
Alias Born 02/23/2010

WorstLuck

Re: None

Monday, 01/27/2025 7:42:07 AM

Monday, January 27, 2025 7:42:07 AM

Post# of 257468
ALLK Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring
https://investor.allakos.com/news-releases/news-release-details/allakos-announces-topline-results-its-phase-1-trial-ak006

The 'announces restructuring' tells you the results.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today